INVO Fertility, Inc. (IVF) vs NewcelX Ltd. (NCEL)

A side-by-side comparison of INVO Fertility, Inc. and NewcelX Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IVF vs NCEL

growth of $100 · dividends reinvested · last 6y
IVF -100.0% (-85.5%/yr)NCEL -99.8% (-63.2%/yr)NCEL compounded faster over this window
Log scale — wide-divergence pair
00001101001kStart $10020222023202420252026$0$0
IVF NCEL

IVF vs NCEL: by the numbers

  • •IVF is the larger company ($1M vs $1M market cap).
  • •Both run net losses; NCEL's is the smaller (0.00% vs -70.18% net margin).

Metrics side by side

Valuation

MetricIVFNCEL
P/S ratio0.19N/A
P/B ratio0.090.22

Profitability

MetricIVFNCEL
Gross margin33.34%0.00%
Operating margin-78.72%0.00%
Net margin-70.18%0.00%
ROE-32.05%-114.48%
ROIC-28.43%-32.53%

Growth (annualized)

MetricIVFNCEL
Revenue CAGR (5Y)39.51%N/A
Total return CAGR (5Y)-90.41%-68.96%

Frequently asked

How have IVF and NCEL total returns compared?
Over the past 5 years, IVF delivered -90.41% and NCEL delivered -68.96% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.